Drugs / Polyribosil-Ribitol-Phosphate (PRP) vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00169442 | Feb 2005 → Mar 2006 | diphtheria, haemophilus infectious disease, hepatitis B virus infection, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polyribosil-Ribitol-Phosphate (PRP) vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00169442 ↗ |
| Modality | Vaccine | “polysaccharide vaccine” NCT00169442 ↗ |
| Route | Intramuscular | “administered intramuscularly into the right upper thigh” NCT00169442 ↗ |